Alnylam Pharmaceuticals
(ALNY)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2019 | 03-2019 | 12-2018 | 09-2018 | 06-2018 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -401,396 | -181,915 | -761,497 | -550,056 | -304,774 |
| Depreciation Amortization | 26,278 | 14,093 | 15,248 | 5,822 | 5,417 |
| Accounts receivable | -11,934 | -15,041 | 15,242 | 30,640 | 31,041 |
| Accounts payable and accrued liabilities | N/A | -24,332 | 74,835 | -650 | -9,735 |
| Other Working Capital | 424,014 | -51,645 | 45,099 | 10,847 | 8,899 |
| Other Operating Activity | 63,223 | 70,330 | 48,457 | 91,238 | 10,801 |
| Operating Cash Flow | $100,185 | $-188,510 | $-562,616 | $-412,159 | $-258,351 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -121,457 | 146,701 | 414,657 | 128,180 | -13,403 |
| PPE Investments | -65,293 | -44,049 | -126,887 | -89,374 | -43,965 |
| Purchase Of Investment | N/A | N/A | -14,825 | -14,825 | -14,825 |
| Investing Cash Flow | $-186,750 | $102,652 | $272,945 | $23,981 | $-72,193 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 803,541 | 390,931 | 65,470 | 60,092 | 47,735 |
| Common Stock Repurchased | N/A | N/A | N/A | N/A | -632 |
| Financing Cash Flow | $803,541 | $390,931 | $65,470 | $60,092 | $47,103 |
| Exchange Rate Effect | -3 | N/A | N/A | N/A | N/A |
| Beginning Cash Position | 422,631 | 422,631 | 646,832 | 646,832 | 646,832 |
| End Cash Position | 1,139,604 | 727,704 | 422,631 | 318,746 | 363,391 |
| Net Cash Flow | $716,973 | $305,073 | $-224,201 | $-328,086 | $-283,441 |
| Free Cash Flow | |||||
| Operating Cash Flow | 100,185 | -188,510 | -562,616 | -412,159 | -258,351 |
| Capital Expenditure | -65,293 | -44,049 | -126,887 | -89,374 | -43,965 |
| Free Cash Flow | 34,892 | -232,559 | -689,503 | -501,533 | -302,316 |